Nonetheless, as the complement pathway is one of the first immune systems activated in response to inflammation, and complement proteins appears to play a dual role in adipose tissue, understanding the metabolism-immunity crosstalk of the complement pathway in WAT may identify strategies and therapeutic avenues for targeting insulin resistance and/or type 2 diabetes. The gene discussed is VTN; the disease is Insulin resistance.